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In Bacteroidetes, one of the dominant phyla of the mammalian gut, active uptake of large
nutrients across the outer membrane is mediated by SusCD protein complexes via a “pedal
bin” transport mechanism. However, many features of SusCD function in glycan uptake
remain unclear, including ligand binding, the role of the SusD lid and the size limit for
substrate transport. Here we characterise the β2,6 fructo-oligosaccharide (FOS) importing
SusCD from Bacteroides thetaiotaomicron (Bt1762-Bt1763) to shed light on SusCD function.
Co-crystal structures reveal residues involved in glycan recognition and suggest that the large
binding cavity can accommodate several substrate molecules, each up to ~2.5 kDa in size, a
finding supported by native mass spectrometry and isothermal titration calorimetry. Muta-
tional studies in vivo provide functional insights into the key structural features of the SusCD
apparatus and cryo-EM of the intact dimeric SusCD complex reveals several distinct states of
the transporter, directly visualising the dynamics of the pedal bin transport mechanism.
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The human large intestine is home to a complex microbialcommunity, known as the gut microbiota, which plays akey role in host biology1–3. One such role is to mediate the
breakdown of complex glycans, which would otherwise be una-
vailable to the host because the human digestive tract lacks the
necessary enzymes4–7. The products of this anaerobic glycan
metabolism are short-chain fatty acids, which provide a range of
both localised and systemic health benefits to the host8,9. In the
colon, the microbiota is dominated by two bacterial phyla, the
Gram-negative Bacteroidetes and Gram-positive Firmicutes1,10.
The Bacteroidetes are glycan generalists and individual species
often have the capacity to utilise a wide diversity of poly-
saccharides from plant, microbial and host sources7,11,12. The
glycan-degrading apparatus in Bacteroidetes is encoded by co-
regulated gene clusters known as polysaccharide utilisation loci
(PULs), with each PUL encoding all of the proteins required for
the acquisition and degradation of a specific glycan7,13. For
example, the model gut symbiont Bacteroides thetaiotaomicron
(B. theta) has 88 predicted PULs14, although only a limited
number have been characterised12. Most glycan degradation
occurs intracellularly, and import of the substrate molecules
across the outer membrane (OM) is mediated by a class of PUL-
encoded TonB-dependent transporters (TBDTs) known as SusCs
(we propose to re-purpose the term “Sus” for saccharide uptake
system rather than starch utilisation system)7,12,13,15. SusC pro-
teins are unique among TBDTs in that they are tightly associated
with a SusD substrate-binding lipoprotein15–17 (Fig. 1a).
Recently, we showed that SusCD complexes mediate substrate
uptake via a “pedal bin” mechanism15,17. The SusC transporter
forms the barrel of the bin, while SusD sits on top of the barrel,
opening and closing like a lid to facilitate substrate binding.
Previous structures of loaded SusCD complexes revealed a bound
ligand, which was completely encapsulated by the closed pedal
bin, indicating that SusCD transporters may have a size limit for
transport15,17. An investigation on the prototypical SusCD system
revealed that a mutant strain lacking the surface endo-amylase
preferentially utilised malto-oligosaccharides with a degree of
polymerisation (DP) of 5–16 (DP5–16)18, suggesting that this is
the preferred size range imported by the Bt3701-02 SusCD
transporter. Direct evidence for this notion is lacking, however,
and this issue has not been explored for any other Sus systems12.
Furthermore, many other key features of SusCD function remain
unclear, including the role of the SusD lid and other conserved
structural elements, as well as the identity of the glycan recog-
nition elements of both SusC and SusD.
One example of a typical PUL is the B. theta levan utilisation
locus, spanning Bt1754-Bt176519. Levan is a fructan polysaccharide
that comprises β2,6-linked fructose units, with occasional β2,1
fructose branches and is produced mainly by bacteria as an exo-
polysaccharide, but also by some cereal plants such as wheat20–23.
For the levan utilisation system, the cell surface components are
Bt1760 (a GH32 endo-levanase), Bt1761 (a surface glycan-binding
protein; SGBP), Bt1762 (SusD) and Bt1763 (SusC)15,19,24 (Fig. 1a).
The cell surface levanase Bt1760 and glycan-binding proteins
(Bt1761 SGBP and Bt1762 SusD) have been shown to be specific for
levan, with no activity against, or binding to, β2,1-linked inulin-type
fructans that are common to many plants19,25.
In this study, we characterise binding and uptake of β2,6
fructo-oligosaccharides (FOS) by the Bt1762-63 SusCD trans-
porter. Co-crystal structures of the closed complex with bound
glycans reveal the residues involved in substrate recognition and
suggest that the large binding cavity can contain several substrate
molecules, each up to ~2.5 kDa in size, a finding supported by
native mass spectrometry (MS) and isothermal titration calori-
metry (ITC). Mutational studies in vivo provide insights into the
key structural features of the SusCD apparatus and cryo-electron
microscopy (EM) of the intact SusC2D2 complex reveals several
distinct states of the transporter, that is, open-open (OO), open-
closed (OC) and closed-closed (CC). These structures directly
visualise the dynamics of the pedal bin mechanism and suggest
that the individual SusCD complexes function independently of
each other. Taken together, these results provide important
insights into the mechanism of glycan import by SusCD com-
plexes of dominant gut bacteria.
Results
A FOS co-crystal structure reveals SusCD residues involved in
ligand binding. In the B. theta levan PUL, the periplasmic
enzymes are GH32 exo-acting fructosidases that release fructose
from the imported β2,6 FOS (Fig. 1a, b)19,24. The fructose is
recognised by the periplasmic domain of the PUL
sensor–regulator BT1754, which upregulates expression of the
PUL19. Thus, by growing B. theta on fructose, large amounts of
the Bt1762-63 transporter can be obtained for structural work15.
A previous crystal structure of Bt1762-63 obtained in the
absence of levan substrate revealed a dimeric (SusC2D2) closed
state in which the SusC TBDT (Bt1763) lacked the plug domain
as a result of proteolytic cleavage15. To provide further insight
into glycan recognition and transport by SusCD complexes, we
determined a co-crystal structure with β2,6-linked FOS using data
to 2.69 Å resolution (Fig. 1c–e; Supplementary Table 1). The FOS
were generated by partial digestion of levan by Bt1760 endo-
levanase, followed by size-exclusion chromatography (SEC) and
analysis by thin-layer chromatography (TLC) and MS. In this
structure, containing relatively short FOS (~DP6–12), the plug
domain is present. Like the oligopeptide ligands in the Bt2261-64
and RagAB structures15,17, the FOS is bound at the top of a large,
solvent-excluded cavity formed by the Bt1762-63 complex
(Supplementary Fig. 1). Density for six β2,6-linked fructose units
can be assigned in the structure and this was designated as the
primary binding site (Fig. 2a). The bound oligosaccharide is
compact and has a twisted, somewhat helical conformation,
similar to that observed for levantetraose in complex with the
endo-levanase26. The ligand makes numerous polar contacts with
side chains of residues in both Bt1762 and Bt1763 (Fig. 2b). For
Bt1762 (SusD), these residues are D41, N43, D67, R368 and Y395,
and for Bt1763 (SusC), T380, D383, D406 and N901. In addition,
prominent stacking interactions are present between the ring of
fructose 2 (Frc 2) and W85 of Bt1762. Interestingly, a β2,1
decoration is present in the bound ligand at Frc 4, and the branch
point interacts with the extensive non-polar surface provided by
the vicinal disulfide between Cys298 and Cys299 of Bt1762
(Fig. 2b), suggesting that the transporter may have some
specificity for FOS with a β2,1 decoration, or alternatively, that
the Erwinia levan used contains many β2,1 branches such that
most of the levanase products are decorated. Previous studies
have shown the proportion of β2,1 linkages in levan from Erwinia
herbicola23 to be ~10%, suggesting that ~2 out of every 3 β2,6
hexasaccharides would be decorated.
Surprisingly, the structure contains a second ligand molecule at
the bottom of the SusC cavity, contacting the plug (FOS2;
Fig. 1d, e, left panel). Density for four fructose units can be seen in
this secondary binding site, and polar contacts are made with
Bt1763 residues Q372, K454, E481 and W483 in the barrel wall,
and with H169 and E170 in the plug domain (Fig. 2c). The fit to
the FOS2 density is slightly better for a 3-mer with a β2,1
decoration compared to a β2,6-linked 4-mer. The relatively small
size of the co-crystallised FOS, combined with the relative
orientation and the large distance between FOS1 and FOS2
(>20 Å; Fig. 1c), makes it highly plausible that there are two ligand
molecules in the Bt1762-63 cavity.
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Next, we obtained a structure without a substrate using a
protein preparation that did not suffer from proteolysis (Fig. 1e,
middle panel; Supplementary Table 1). Interestingly, while this
structure is very similar to that reported earlier15, density for the
plug domain is poor but clearly present (Supplementary Fig. 2),
suggesting mobility or different conformations of the plug within
the barrel. While there is no density supporting this notion, it is
also possible that the plug has been ejected from some of the
Bt1763 barrels in the crystal. Consistent with the relatively high
solvent content of the crystals (~63%), there are large spaces
underneath the barrels that could contain ejected and mobile plug
domains (Supplementary Fig. 2d). This would allow inadvertent
proteolytic cleavage of the plug domain as observed in our
previous apo-Bt1762-63 structure (PDB ID 5T3R)15.
We next added longer β2,6 FOS (~DP15–25) to the same
protein preparation used for the apo structure determination, and
obtained another co-crystal structure of Bt1762-63, using data to
3.1 Å resolution (Supplementary Table 1). This structure has very
similar density for a FOS molecule at the principal binding site
(Fig. 1e, right panel) compared to the higher resolution structure
with shorter FOS, suggesting that the additional fructose units in
longer FOS contribute little if anything to binding. The co-crystal
Fig. 1 Structures of Bt1762-63 in the presence of β2,6 FOS. a, b Schematic overview of the B. theta levan Sus apparatus (a), encoded by the PUL spanning
Bt1754-65 (b). NTE is the N-terminal extension of Bt1763. Bt1759 and Bt1765 are periplasmic GH32 β-fructosidases, Bt1757 is a predicted fructokinase and
Bt1758 is a predicted inner membrane (IM) major facilitator superfamily (MFS) transporter. Bt1754 is a hybrid two-component system that binds directly
to fructose in the periplasm to upregulate expression of the PUL (b)19. c Cartoon representation of the Bt1762-63 dimer with bound FOS molecules shown
as stick models, with oxygens coloured red and carbons yellow. Bt1762 (SusD) is coloured green and Bt1763 (SusC) cyan. The plug domain of Bt1763 is
coloured purple. d Close-up cut-away view of the two FOS molecules inside one of the BT1762-63 monomers. e Cartoon comparisons of Bt1762-63 with
shorter FOS (left; PDB ID 9ZAZ; 2.69 Å resolution), without ligand (middle panel; PDB ID 6Z8I; 2.62 Å resolution), and with longer FOS (right; PDB ID
6Z9A; 3.1 Å resolution). The bound FOS molecules are shown as space-filling models. The N-terminal hinge at the back of BT1762, allowing opening of the
transporter at the front (arrow), is labelled for the complex without ligand. Crystal structure figures were made with Pymol (https://pymol.org/2/).
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structure with the longer FOS also shows some density at the
secondary site, but it is of insufficient quality to allow model
building, perhaps due to the lower resolution.
Single-particle cryo-EM reveals different conformational states
of Bt1762-63. The very similar crystal structures of Bt1762-63 in
the absence and presence of FOS appear at odds with the
dynamics proposed in the pedal bin transport model15, but are
likely explained by the fact that crystallisation selects for compact,
stable states. To visualise potential different conformational
states, we used single-particle cryo-EM on detergent-solubilised
apo-Bt1762-63. Following initial two-dimensional classification, it
is clear that Bt1762-63 is dimeric in solution, demonstrating that
the dimers in the crystal structures are not artefacts. Strikingly,
several distinct conformations of the SusC2D2 complex are pre-
sent in a single dataset, and after further classification steps, three
dominant states were identified. Following three-dimensional
(3D) reconstruction, electron density maps were obtained at
resolutions allowing rigid body placement and refinement of
individual protomers. This yielded structures corresponding to
the three possible combinations of open and closed dimeric
transporters: OO (3.9 Å), OC (4.7 Å) and CC (4.2 Å) (Fig. 3,
Supplementary Fig. 3a and Supplementary Table 2).
With the exception of a few Bt1763 loops (L6 and L7;
Supplementary Fig. 3b) and the Bt1762 segment following the
lipid anchor that serves as a pivot around which Bt1762 moves
upon lid opening, the conformational changes between the three
states correspond to rigid body movements of Bt1762. In contrast
to the recently characterised RagAB peptide transporter from
Porphyromonas gingivalis17, the Bt1762-63 cryo-EM dataset
shows evidence of intermediate states of lid opening (Supple-
mentary Fig. 4), suggesting the presence of a number of minima
in the energy landscape for opening and closing of the
transporter. Interestingly, the presence of the plug domain in
the interior of the Bt1763 barrel in solution is strictly correlated
with the open vs. closed state of the transporter; only open states
contain a plug domain, regardless of the state of the SusC2D2
dimer (Fig. 3b). Given that there are no direct contacts between
Bt1762 and the Bt1763 plug domain, this suggests that the
transition from the open to the closed state generates conforma-
tional changes in the barrel of Bt1763, leading to displacement of
the plug domain from the barrel in vitro. Superposition of the
crystal structures of plug-less and complete transporters indeed
show non-uniform displacements of up to ~2–2.5 Å for Cα atoms
of barrel wall residues, which is substantially more than the
coordinate errors of the structures (~0.5 Å), showing that the
barrels have subtly different shapes (Supplementary Fig. 5).
The established model of TonB-dependent transport27 assumes
that extracellular substrate binding to a site that includes residues
from the plug domain induces a conformational change that is
transmitted through the plug domain of the TBDT. This results in
disordering of its N-terminal Ton box and increased accessibility
of the Ton box for interaction with the C-terminal domain (CTD)
of TonB. In the open, apo state of the SusCD transporter as
observed via cryo-EM, the Ton box of Bt1763 (82DEVVVTG88) is
visible, tucked away inside the barrel, and interacts with the body
of the plug (Supplementary Fig. 3c). By contrast, the density in
the crystal structure of the FOS-bound Bt1763 starts only at L97,
indicating that the Ton box is disordered and would likely be
exposed to the periplasmic space. Thus, our structures for
Bt1762-63 are consistent with the proposed behaviour of the Ton
box upon ligand binding by the transporter.
Structure–function studies of Bt1762-63
SusD mutants. The observed interactions of FOS1 with Bt1762
SusD in the co-crystal structures are in excellent agreement with
previous ITC studies of levan binding to recombinant Bt1762
variants with single substitutions of aromatic residues and
cysteines (Fig. 2b)15. The mutations W85A and C298A abolished
in vitro levan binding by Bt1762, whereas the affinity of Y395A
Fig. 2 FOS densities and interactions with the transporter. a 2Fo-Fc density (contoured at 1.0σ, carve= 2) of FOS1 bound in the primary binding site
rotated by 90°. The glycan branch point is indicated with an arrow. b Close-ups of the principal FOS binding site with residues making polar interactions
with the substrate shown as stick models and coloured as in panel (b). Polar interactions are shown as dashed lines, and water molecules as red spheres.
For both Bt1762 and Bt1763, residue numbering is for the mature protein without the signal sequence, that is, starting at C19 for Bt1762 and G26 for Bt1763.
c Close-ups of the FOS2 binding site with polar interactions indicated. Plug residues are coloured purple.
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was ~6-fold weaker than that of wild-type (WT). Single sub-
stitutions of five other aromatic and cysteine residues remote
from the ligand binding site did not affect levan binding15. To
assess how single substitutions that abolish levan binding to
Bt1762 in vitro affect the ability of B. theta to utilise levan in vivo,
a W85A mutant strain was constructed and growth was analysed
using 0.5% Erwinia levan as the sole carbon source. Surprisingly,
there was no growth defect observed for the W85A strain
(Fig. 4a), which, combined with its WT levels of expression
(Fig. 4d, e), indicates this variant is fully functional and that care
is required in drawing conclusions from in vitro binding studies,
especially of the SusD protein in isolation. Clearly, the context of
the intact transporter ensures that the effects of SusD point
mutations may be much less dramatic in vivo. When seven
residues in Bt1762 involved in direct interaction with FOS1
(Fig. 2b; green sticks; D41, N43, D67, W85, C298, R368 and
Y395) were changed to alanine at the same time, the resulting
strain (SusDBR) grew only after a prolonged lag phase of ~8 h,
which is comparable to a strain lacking Bt1762 (ΔSusD; Fig. 4a).
However, the OM levels of the SusDBR mutant are much lower
than that for WT and W85A strains (Fig. 4d, e), providing an
explanation for the observed growth defects. Given these results
for Bt1762 mutants, we opted not to investigate the effect of
Bt1763 binding residue mutations, but instead focused on other
potentially important functional regions of the transporter.
Hinge region mutants. Loop L7 of Bt1763, identified as a “hinge”
loop in previous simulations of Bt2263-6415 and hereafter named
hinge1, is likely to be important for Bt1762 lid opening (Sup-
plementary Fig. 3b). In addition, we identified from the cryo-EM
structures a second loop in Bt1763, L6 (Supplementary Fig. 3b),
as potentially important for lid opening (designated as hinge2).
Fig. 3 Dynamics of pedal bin opening revealed by single-particle cryo-EM. a Electron density filtered by local resolution for Bt1762-63 viewed from the
OM plane for the OO state (left panels), OC state (middle panels) and CC state (right panels). b Presence or absence of the Bt1763 SusC plug domain in
the three principle states from cryo-EM. Local resolution filtered EM density for Bt1762-63 in the open-open (left), closed-open (middle) and closed-closed
(right) states as viewed from the extracellular (top panels) and periplasmic side of the outer membrane (bottom panels). Clear density for the plug domain
(purple) is invariably associated with the open state of the transporter. Where the lid is closed, no density is observed within the barrel of Bt1763. Cryo-EM
figures were made with ChimeraX65.
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Hinge1 and 2 change conformation substantially during lid
opening and are responsible for the majority of interactions
between Bt1762 and Bt1763 in the open state (Supplementary
Fig. 3b). The deletion of hinge1 caused little to no growth defect
(Fig. 4b), which is surprising given that Bt1762-63Δhinge1
expression is very low (Fig. 4d, e) and suggesting that this mutant
might have a higher transport activity than the WT. By contrast,
the Δhinge2 strain showed a complete lack of growth during the
24 h monitoring period, while being expressed at levels similar to
Bt1762-63Δhinge1 or slightly lower (Fig. 4b, d, e). Surprisingly, a
strain in which both hinges were deleted (Bt1762-63Δhinge1&2)
grew similarly to the ΔSusD strain, that is, after an ~8 h lag phase
(Fig. 3b). There is no clear explanation for these phenotypes,
since the expression levels of the double hinge mutant are similar
to those of the single hinge deletions. One possibility is that the
loss of both Bt1763 hinges allows free movement of the Bt1762
lid, which will only be attached to Bt1763 via the N-terminal ~15
residue segment following the Bt1762 lipid anchor. This may
essentially decouple substrate binding by Bt1762 from delivery to
Bt1763, and result in a phenotype that is similar to that of ΔSusD.
We speculate that the complete loss of growth observed in the
Bt1762-63Δhinge2 mutant could be due to a “dominant-negative”
effect on something that does not involve the levan PUL but is
essential for growth, perhaps arising from misfolding of Bt1763
that leads to stalling of the BamA assembly machine.
TonB box and N-terminal extension mutants. SusC-like proteins
are predicted to be TBDTs, but direct evidence for this is lacking.
Fig. 4 Structure–function studies of the Bt1762-63 SusCD levan importer. a–c Growth curves on levan of Bt1762 SusD mutant strains (a), Bt1763 SusC
hinge loop mutant strains (b), and Bt1763 ΔNTE and TonB box mutant strains (c). WT wild-type strain (with His6 tag on C terminus of Bt1762). Growth
curves show mean (solid line) ± SD of triplicate wells and are representative of three independent experiments. d Representative SDS-PAGE gel (n= 3
independent experiments) of IMAC-purified Bt1762-63 complexes from OM fractions of WT (Bt1762-his strain) and mutant strains grown on MM
fructose. The far left lane is MWmarker with the sizes shown in kDa. e Relative expression levels quantified from band intensities on SDS-PAGE gels using
ImageJ (n= 3 independent experiments; means ± SD are shown, plus individual values). Band intensities of WT Bt1762 and Bt1763 were set to 100%.
Source data are provided as a Source Data file.
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We therefore examined the importance of the putative TonB box
located at the N terminus of Bt1763. In addition, SusC proteins
have an N-terminal extension (NTE) domain of ~9 kDa (Pfam
13715, carboxypeptidase D regulatory-like domain) that is absent
in other types of TBDTs and precedes the TonB box, but has an
unknown function (Fig. 1a)28. We constructed two mutant B.
theta strains in which the TonB box was either deleted (residues
81VDEVVV86; ΔTonB box) or mutated to all-Ala (TonB box
mut), and a strain in which the complete NTE was deleted
(residues 3–76; ΔNTE), but with the Ton box intact. Growth of
the mutants on levan as the sole carbon source revealed that both
TonB box mutant strains had similar growth defects to that of
ΔSusD, and were expressed at reasonable levels (~50% of WT;
Fig. 4c–e), demonstrating that Bt1763 is a bona fide TBDT. This
result also suggests that all mutants with growth lag phases longer
than 8 h are non-functional, and that the observed growth in
these cases is caused by a build-up of small FOS products gen-
erated by the surface endo-levanase, which enter the cell via
passive diffusion independently of levan PUL components.
Remarkably, the ΔNTE strain has a similar phenotype to Bt1762-
63Δhinge2 with no detectable growth after 24 h, despite expression
levels of ~25–50% that of WT, indicating an important role for
this domain in transporter biogenesis or cellular function that
perhaps might not involve the transport process itself.
Solution NMR structure shows an immunoglobulin (Ig)-like
fold for the NTE. The striking, dominant-negative effect of the
ΔNTE mutant on growth made it important to determine the
structure of the isolated NTE, since it is invisible in the X-ray
structures and has a very weak density in the cryo-EM structures.
Crystallisation trials proved unsuccessful, and we, therefore,
solved the structure by high-resolution nuclear magnetic reso-
nance (NMR) spectroscopy, using uniformly 15N,13C-labelled
protein produced in Escherichia coli (Supplementary Fig. 6). A 2D
[15N,1H]-HSQC spectrum of the NTE showed good chemical
shift dispersion and the expected number of resonances (Fig. 5a).
Complete sequence-specific assignments for the backbone reso-
nances were then obtained using a combination of 2D and 3D
experiments (Supplementary Tables 3 and 4 and Supplementary
Fig. 6). Backbone chemical shifts were compared to the random
coil values, resulting in the identification of seven β-strands. A
total of 964 distance constraints were obtained from 3D nuclear
Overhauser effect spectroscopy (NOESY) spectra, and served as
input for structure calculations in CYANA. The final ensemble of
20 lowest-energy structures had a root-mean-square deviation
(r.m.s.d.) of 0.52 Å for the backbone heavy atoms (Fig. 5b, Sup-
plementary Fig. 6 and Supplementary Tables 3 and 4). The NTE
structure shows a well-defined core of an Ig-like fold with a 7-
stranded barrel (Fig. 5c, left panel). The N terminus (including
the His-tag) and the C terminus, corresponding to the Ton box,
are flexibly unstructured, as evidenced from their random coil
chemical shifts and the absence of long-range NOEs (Fig. 5b and
Supplementary Fig. 6c).
A distance-matrix alignment (DALI) analysis29 returned a
number of structures with significant similarity, the highest of
which had a Z-score of 10.2 (transthyretin-like domain of
carboxypeptidase D, PDB ID 5aq0; Supplementary Fig. 7).
However, none of the DALI hits provided any insights into a
potential function of the NTE. In Proteobacteria, structures of
TBDTs with a different N-terminal domain, designated STN
(Pfam 07660), have been reported. This STN domain has a
similar size as the NTE and has an established role in signalling,
where it interacts directly with an anti-sigma factor in the inner
membrane to stimulate TBDT expression in response to the
presence of their cognate substrates27,30–33. Notably, SusCs from
ECF-sigma/anti-sigma controlled PULs also contain STN
domains in addition to an NTE domain, with the NTE preceding
the STN in all cases34. STN domains in SusCs have also been
shown to be involved in anti-sigma signalling, indicating that the
NTE domain in SusCs has a different role compared to the
STN34. The structure of the FoxA STN in complex with the CTD
of TonB shows that the structure of the STN is different from that
of the NTE, with the STN containing two helical segments and
having a different topology (Fig. 5c, d)35. In both domains, the
Ton box is separated from the domain body and will be accessible
to binding by the CTD of TonB. One intriguing possibility for a
role for the NTE could be to provide interaction specificity for the
multiple TonB orthologs present in the B. theta genome.
Investigation of the size range of FOS import by Bt1762-
Bt1763. The co-crystal structures of Bt1762-63 with FOS, as well
as the previously published structures of Bt2261-6415 and
RagAB17, show that ligands are encapsulated within a large,
solvent-inaccessible cavity formed by the closure of the SusD lid,
strongly suggesting that there is a size limit for substrate import.
This hypothesis is further supported by previous studies showing
that growth of B. ovatus and B. thetaiotaomicron on large poly-
saccharides, such as xylan and starch, requires the action of PUL-
encoded surface endo-acting enzymes to cleave the glycans into
smaller oligosaccharides prior to import36,37. In addition, uptake
of monosaccharides and even very small oligosaccharides does
not appear to require a functional Sus apparatus, suggesting that
Fig. 5 Solution NMR structure of the Bt1763 NTE shows a 7-stranded
barrel. a 2D [15N,1H]-HSQC spectrum of the NTE. b Ensemble of the 20
lowest-energy structures of the NTE presented in stick view for the main
chain. The N and C termini are labelled. c Lowest-energy NMR structure
from the ensemble of panel (b) in ribbon representation, coloured in
rainbow mode (N terminus; blue). d STN domain of Pseudomonas aeruginosa
FoxA (PDB ID 6I97) in the same colouring mode. The Ton boxes of each
domain (82DEVVVTG88 in Bt1763; based on the alignment with FoxA) are
coloured magenta.
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there may also be a minimum size limit for transport by SusCD
complexes38. To shed light on this issue, we used ITC to inves-
tigate the size range of FOS recognised by Bt1762-63. The β2,6
FOS was produced by digestion of Erwinia levan with Bt1760
endo-levanase, followed by separation via SEC (“Methods”). For
estimation of the DP of each oligosaccharide, we used both TLC
and MS (Supplementary Fig. 8). While this was effective for FOS
with a DP 4 to ~12, FOS larger than ~DP14 do not move from
the origin in TLC, and the MS analysis of FOS larger than ~DP12
proved difficult because of poor ionisation efficiency of longer
oligosaccharide molecules. It is however clear that the higher DP
FOS fractions contain a wide range of sizes.
ITC revealed that Bt1762-63 binds to the majority of FOS
examined, with only the tetra-saccharide displaying no affinity for
the transporter (Fig. 6, Supplementary Fig. 9 and Supplementary
Table 5). For the larger FOS, affinity increased from DP5–6 (Kd ~ 30
and 17 µM, respectively) and plateaued at DP8 (tube 174, T174
Kd ~ 1 µM), with Bt1762-63 binding to all FOS between DP8 and
at least DP13–14 (T115) with similar affinity. These data are in
broad agreement with the co-crystal structures, which show well-
defined density for 7 fructose units in the primary binding site,
suggesting that these provide the bulk of the binding interactions.
Surprisingly, no binding was detected for the FOS in SEC
fractions T114 and T113, despite these fractions having similar
MS profiles to T115 with a broad range of oligosaccharides
present (Fig. 6 and Supplementary Fig. 8). The average molecular
weight of the FOS in tube T114 (Mn > 2666) is larger than that of
T115 (Mn > 2193; Supplementary Fig. 8), and it may be that this
increase in average size is enough to preclude binding to the
transporter. Furthermore, based on the co-crystal structure, we
can see that at least some, and perhaps all, of the bound Erwinia
levan-derived FOS has a β2,1 decoration, which may influence
binding to Bt1762-63. However, it was not possible to identify
β2,1 decorations in the TLC or MS analysis. Thus, T115 FOS
Fig. 6 FOS binding to Bt1762-63 analysed by ITC. β2,6 FOS fractions from SEC of partially digested Erwinia levan were titrated into purified Bt1762-63
SusCD (25 or 50 µM) in 100mM HEPES, pH 7.5 containing 0.05% LDAO. The identity of the fraction used is indicated as is the approximate DP of the
main FOS species present as determined by MS. The W85A mutant is for SusD in the complex (i.e. Bt1762W85A-63). The upper parts of each titration show
the raw heats of injection and the lower parts the integrated heats fit to a one set of sites model if binding was observed.
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might contain significantly more branched species than T114 and
this could explain a higher affinity for the T115 fraction. Taken
together, however, these data indicate that there is both an upper
and lower size limit for FOS binding to the Bt1762-63 transporter
in vitro, with the lower limit being DP5 and the upper limit
~DP15. In addition to WT Bt1762-63, we also measured binding
of ~DP9 FOS to the Bt1762W85A-63 variant (Fig. 6). Surprisingly,
no binding is observed for the mutant, even though the
Bt1762W85A-63 strain grows as well as WT on levan (Fig. 3a),
suggesting that a native level of FOS binding by Bt1762-63 is not
essential for Bt1762-63 function in vivo. A possible explanation
for this observation is that in the presence of high concentrations
of FOS, substrate binding to Bt1762 is not needed to load the
Bt1763 transporter. The contrasting, loss-of-function phenotype
of SusDBR can be explained by the very low expression levels for
this mutant (Fig. 4).
We used native MS to shed further light on the ligand binding
property of the Bt1762-63 complex. For the ligand-free protein,
the mass spectrum revealed charge states corresponding to the
intact SusC2D2 dimeric complex and low-intensity peaks assigned
to SusCD monomer (Supplementary Fig. 10). Ligand binding
appeared to induce considerable destabilization of the SusC2D2
complex as reflected in the higher intensity of monomer peaks in
the presence of FOS molecules. Specifically, binding of the FOS
fractions characterised by DP > 14 (T115) and DP > 16 (T114)
yielded low-intensity adducts to the intact SusC2D2 consistent
with substrate binding for both samples. While this appears
surprising, it should be noted that higher ratios of FOS:protein
were used in MS compared to ITC (~6-fold vs. ~2-fold,
respectively), providing a possible explanation for the lack of
observed binding in ITC for T114. The complexity of the binding
pattern in the spectrum is consistent with polydispersity of the
T114 and T115 fractions (Supplementary Fig. 8). More useful
insights were obtained with the T159 sample, which consists
mainly of FOS with 7–10 fructose units (~DP9) (Fig. 7 and
Supplementary Fig. 8). These medium-chain oligosaccharides
bind preferentially to the intact SusC2D2 dimer rather than to the
SusCD monomer such that no ligand-free dimer was evident in
the spectrum, potentially suggesting some kind of cooperativity
for ligand binding in the dimer. Interestingly, the relative
proportions of protein-bound FOS mirrored their abundance in
the T159 sample (Fig. 7b), supporting the similar affinities of FOS
with 8–10 fructose units for Bt1762-63 as measured by ITC (Fig. 6
and Supplementary Table 5). At the higher FOS concentrations,
binding of more than one FOS molecule per SusCD transporter
was observed (Fig. 7b), confirming the observation from our co-
crystal structure that more than one ligand molecule can be
present in the binding cavity, at least for the relatively small FOS.
Finally, we wanted to confirm the upper FOS size limit in vivo
by testing growth of a strain lacking the surface endo-levanase
Bt1760 with FOS of different sizes as the sole carbon source. The
Δ1760 strain was previously reported to lack the ability to grow
on levan19, which would provide another indication that the
Bt1762-63 complex cannot import high molecular weight
substrates. Surprisingly, however, the growth rate of the
Δ1760 strain on levan from several different sources was similar
or only slightly slower than that of the WT strain (Supplementary
Fig. 11). Polymerase chain reaction (PCR) of the Δ1760 cells
taken from stationary phase of the cultures confirmed the
deletion of the Bt1760 gene from the cells, indicating that the
phenotype was not due to contamination with WT strain
(Supplementary Fig. 11). These data suggest that all levans tested
contained enough low DP FOS to allow growth without needing
digestion by the surface endo-levanase. The spent media collected
after culturing the Δ1760 strain did not support growth of the
mutant strain after re-inoculation. However, it was not possible to
obtain size estimations of the remaining FOS via either HPAEC-
PAD or MS, due to the technical limitations of separation and
ionisation, respectively, of FOS at this high DP. It was therefore
not possible to determine an upper FOS size limit of the Bt1762-
63 importer in vivo.
Discussion
The difficulty in ionising large oligosaccharides in the mass
spectrometer39 complicates the reliable experimental determina-
tion of an upper substrate size limit of SusCD-like systems. Even
if large oligosaccharides could be detected via MS, the inability to
separate high DP FOS (>~DP12) by SEC precludes estimation of
detection efficiency, and consequently quantitation. Despite this,
some important insights can be obtained via simple structural
considerations. The ligand binding cavity of Bt1762-63 has a
volume of ~10,000 Å3 as determined via CASTp40, which is
similar to that of the peptide importer RagAB17. While no
information is available for FOS, data for sucrose41 allow an
estimation of ~500 Å3 per fully hydrated molecule, with five
waters per sucrose. For one bound water per sucrose, the molar
volume is lowered by ~20%, leading to a value of 400 Å3 per
sucrose. Thus, depending on FOS hydration inside the Bt1762-63
cavity and assuming ideal packing, there would be space for
20–25 sucrose molecules, that is, 40–50 sugar monomers. Given
that it is unlikely that the twisted structures of levan FOS could
pack very efficiently, we estimate that the maximum number of
fructose units occupying the Bt1762-63 cavity at any one time
could be no more than ~30–35, putting an upper limit on total
bound FOS of ~5 kDa. Considering our ITC and native MS data,
it is likely that this total mass would comprise several individual
molecules, rather than one large molecule. Given that there are
unlikely to be large structural differences among SusCD-like
systems, we suggest ~5 kDa as a general total size limit for these
transporters, which is consistent with recent data for the arche-
typal Sus18.
Our structures that show FOS in the principal binding site at
the Bt1762-63 interface raise an important question: how is ligand
occupancy relayed to the plug domain, and how does this lead to
increased accessibility of the Ton box? This key issue is likely
unique to SusCD systems, in particular, those SusCs without the
long plug loop present in, for example, Bt226415 that is able to
contact ligand in the principal binding site and relay binding site
occupancy directly to the plug domain (Supplementary Fig. 12).
In Bt1763, the smallest distance between the visible part of the
substrate in the principal binding site and the plug is 15 Å, and so
an optimal-sized FOS (in terms of binding affinity) of ~DP8–12
could not contact the plug directly. The presence of a second
substrate molecule at the bottom of the binding cavity (Fig. 1d)
might be a way to overcome this problem, implying a mechanism
in which the binding cavity “bin” is filled first via two or more
substrate binding-release cycles to provide plug contacts, that
collectively increase the accessibility of the Ton box and binding
to the CTD of TonB.
The substrates for the transporter are generated by the com-
bined action of the Bt1760 endo-levanase and the Bt1761 SGBP
(Fig. 1a). It is not yet clear if, and how, these two proteins are
spatially and temporally connected to the Bt1762-63 transporter.
For the archetypal Sus, data suggest that all five OM components
of the PUL (SusCDEFG) are arranged in one stable complex16,42.
Other, more recent studies paint a much more dynamic picture,
with the SGBPs (SusE and SusF) and the endo-amylase SusG
transiently associating with the SusCD core complex43,44. Besides
depending on the type of levan25, the FOS sizes delivered to
Bt1762-63 will depend critically on the binding kinetics of the
Bt1760 levanase and on the proximity of Bt1761: a close
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20285-y ARTICLE
NATURE COMMUNICATIONS |           (2021) 12:44 | https://doi.org/10.1038/s41467-020-20285-y | www.nature.com/naturecommunications 9
association between the two would most likely favour production
of uniformly sized FOS of relatively small size, which, as we have
shown, are preferred substrates. Likewise, a close association
between the enzyme and Bt1762-63 will enhance the capture of
the generated FOS by SusD and subsequent delivery to SusC.
With regards to this last step, it is interesting to note that, in
contrast to in vitro conditions, the substrate binding function of
Bt1762 is not necessary in vivo (Fig. 4 and Fig. 6), that is, when all
other OM components are present (Bt1760/61/63), and similar
data have recently been obtained for other Sus18,45. These
observations would suggest that the SGBP can assume the
substrate-delivery role of SusD and argues in favour of an inti-
mate association of all OM components of a PUL. This then
raises the question of why the SusD lid has evolved at all. The fact
that the presence of SusD is important in vivo (Fig. 4) suggests
that its function as a lid that can open and close is vital.
Our structural data provide important clues about the function
of SusD and about glycan import in general (Fig. 8). The basis for
these clues is the unprecedented observation that closed, but
empty transporters lack the entire plug domain. This spontaneous
expulsion of the plug is likely to be non-physiological and caused
by a loss of lateral membrane pressure due to detergent solubi-
lisation. Nevertheless, it does suggest that Bt1762 lid closure
causes conformational changes within the Bt1763 barrel that
decrease the “affinity” of the plug for the barrel. This may facil-
itate the removal of the entire plug domain from the barrel by
TonB action, as opposed to local unfolding and formation of a
relatively narrow channel as has been proposed for non-Sus
Fig. 7 Bt1762-63 binding to medium-chain fructo-oligosaccharide (FOS). a Native mass spectrum of Bt1762-63 bound to FOS T159 fraction (~DP9)
revealed the presence of both bound and unbound SusCD monomers, but only FOS-bound SusC2D2 dimers. The inset shows the spectrum of the FOS T159
fraction. b Spectrum of Bt1762-63 incubated with different concentrations of FOS T159. Shown are individual charge states of the monomer (+23) and of
the dimer (+32). Up to two and four FOS molecules (mainly 8–10 fructose units) were found to bind to SusCD and SusC2D2, respectively. Masses of all
species observed are listed in Supplementary Table 6.
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TBDTs46–48. To prevent plug removal in the absence of substrate
resulting in futile transport cycles, we postulate that only the
direct contact of substrate with the plug (as observed in the co-
crystal structure with FOS2 and the in Bt2263/64–peptide com-
plex15) leads to increased accessibility of the TonB box and
interaction with TonB (Fig. 8). In our model, the impermeability
of the OM, which otherwise would be compromised due to the
formation of a very large channel of ~20–25 Å diameter, would be
preserved by the seal provided by the closed SusD lid. Upon
reinsertion of the plug, the transporter would revert back to its
open state (Fig. 8). The most important function of SusD proteins
during glycan import may therefore be to provide a seal to pre-
serve the OM permeability barrier.
Methods
Maintenance and growth of bacterial strains. Brain heart infusion (BHI) media
and agar, supplemented with 1 µg/ml haematin, or where needed with gentamycin
(200 µg/ml) and erythromycin (25 µg/ml), was used for routine selection and
maintenance of B. thetaiotaomicron VPI-5482 (B. theta) WT and mutant strains.
Luria-Bertani media and agar, supplemented where needed with kanamycin
(50 µg/ml) or ampicillin (100 µg/ml), was used for routine selection and main-
tenance of E. coli strains. Cultures for B. theta protein purification were grown in a
chemically defined minimal media (MM), NH4SO4 1 mg/ml, Na2CO3 1 mg/ml,
cysteine 0.5 mg/ml, KPO4 100 mM, vitamin K 1 µg/ml, FeSO4 4 µg/ml, vitamin
B12 5 ng/ml, mineral salts 50 µl/ml (NaCl 0.9 mg/ml, CaCl2 26.5 µg/ml, MgCl2
20 µg/ml, MnCl2 10 µg/ml and CoCl2 10 µg/ml) and haematin 1 µg/ml. These
cultures were supplemented with D-fructose (0.5% final) as the sole carbon source
to yield MM-Frc (MM fructose). Frc activates the levan PUL, but does not require
Bt1762-63 for import. All B. theta growths were carried out under anaerobic
conditions at 37 °C (A35 Workstation, Don Whitley Scientific).
Gene cloning and construction of B. theta mutants. The desired genetic
sequence containing mutations or deletions was amplified through two rounds of
PCR, including ~1000 bp upstream and downstream of the deletion or mutation.
The primers used to generate these PCR products are listed in Supplementary
Table 7. Briefly, for the TonB deletion strain primers TB-fwd, TBD-rev and TBD-
fwd, TB-rev respectively were used to make 1000 bp fragments, which underwent
an additional PCR to construct the 2000 bp sequence. The same process was used
to make mutants TonB mutation (TB-fwd, TBM-rev and TBM-fwd, TB-rev),
Δhinge1 (Hinge-fwd, H1D-rev and HD1-fwd, Hinge-rev), Δhinge2 (Hinge-fwd,
HD2-rev and HD2-fwd, hingerev), W85A (Trp1-fwd, Trp2-rev and Trp3-fwd,
Trp4-rev), and ΔNTE (NTE1-fwd, NTE2-rev and NTE3-fwd, NTE4-rev).The final
PCR product was ligated into pExchange-tdk vector38.
B. theta genetic deletions and mutations were created by allelic exchange using
the pExchange-tdk vector. Briefly, the constructed pExchange-tdk plasmids,
containing the mutations/deletions plus ~1000 bp flanks up- and downstream,
were transformed into S17 λ pir E. coli cells, in order to achieve conjugation with
the B. theta recipient strain38. The conjugation plates were scraped to generate a
culture containing B. theta and E. coli. B. theta cells undergoing a single
recombination event were selected by plating on BHI-haematin agar plates
containing gentamycin (200 μg/ml) and erythromycin (25 μg/ml), and 8–12
colonies were restreaked on fresh BHI-haematin-gent-ery plates. Single colonies
were cultured in BHI-haematin and pooled. To select for the second recombination
event, pooled cultures were plated on BHI-haematin agar plates containing 5-
fluorodeoxyuridine (FUdR; 200 μg/ml). FUdR-resistant colonies, 8–12, were
restreaked on fresh BHI-haematin-FUdR. From these, single colonies were cultured
in BHI and genomic DNA was extracted and screened for the correct mutations
using diagnostic PCR and sequencing. DNA-sequencing was performed by MWG-
Eurofins.
Expression and purification of native proteins. The required strain of B. theta
was inoculated from −80 °C stocks into 5 ml BHI supplemented with haematin,
1 µg/ml. These were cultured overnight and used to inoculate 500 ml Duran bottles
containing 500 ml MM supplemented with haematin and either fructose or levan
(0.5%) as the sole carbon source and grown for 18–20 h. The following morning,
cells were harvested by centrifugation at 11,305 × g for 25 min, and the pellets were
resuspended in Tris salt buffer (TSB; 20 mM Tris, 300 mM NaCl, pH 8) and stored
at −20 °C.
One protease inhibitor tablet (Complete Mini, EDTA free; Roche) and DNaseI
(Roche) were added to the completely thawed cells from 4 l of culture before (total
volume ~100 ml) being lysed in a cell disrupter (Constant Systems; 0.75 kW model)
at 23 kilopounds per square inch. The lysed cells were centrifuged for 1 h at
204,526 × g (45Ti rotor, Beckman). The resultant pellet, containing total
membranes, was homogenised in 100 ml 0.5% sodium lauroyl sarcosine (sarkosyl),
20 mM HEPES, pH 7.5. The sample was stirred slowly at room temperature for 20
min before centrifugation for 30 min at 204,526 × g. The supernatant was discarded
and the pellet was homogenised using a glass dounce in 20 mM Tris, 300 mM NaCl
pH 8.0 (TSB buffer) containing 1.5% lauryldimethylamine-N-oxide (LDAO), and
incubated at 4 °C with stirring for 1 h. Typically, 100 ml of this buffer was used to
extract the OM from 4 l of culture. The sample underwent centrifugation at
204,526 × g for 30 min (45Ti rotor, Beckman) and the supernatant, containing the
Fig. 8 Model demonstrating the proposed mechanism of substrate capture and translocation by Bt1762-63. Levan polysaccharide is initially bound and
hydrolysed at the cell surface by the SGBP Bt1761 and GH32 endo-levanase Bt1760, respectively, although the precise role of the SGBP is unclear. A lid-
open state of the transporter permits binding of transport-competent FOS. ① Contributions from both SusC and SusD to FOS binding elicits closure of the
lid. ② Multiple cycles of lid opening and closing occur until the SusC “bin” is fully loaded with substrate, forming the transport-ready state of the complex.
Substrate loading is communicated across the outer membrane by direct contact with the Bt1763 plug domain, inducing perturbation of the Ton box region
on the periplasmic side of the plug, rendering it accessible to TonB. ③ TonB-mediated disruption/extraction of the plug permits substrate translocation.
Details of the “reset” mechanism are unclear, but reinsertion of the plug is likely a prerequisite to restoring the open state of the transporter.
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extracted OM proteins, was kept. The total protein concentration was determined
using a BCA Protein Assay Kit (Thermo Fisher Scientific).
Bt1762-63 was further purified using an Immobilised Metal Affinity
Chromatography (IMAC) Ni column using the C-terminal His6 tag on SusD
(Bt1762)15. The OM fraction from 4 l of MM-Frc grown B. theta cells was passed
through an ~8–10 ml IMAC Ni column equilibrated with 0.2% LDAO in TSB. The
column was washed with TSB with 0.2% LDAO and 25mM imidazole, and bound
proteins were eluted with TSB containing 0.2% LDAO and 200mM imidazole.
IMAC samples were visualised by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE). Samples from IMAC were further purified by SEC.
An ÄKTA pure system (GE Healthcare) was used in conjunction with a HiLoad 16/
60 Superdex 200 pg 120 ml gel filtration column (GE Healthcare). The column was
equilibrated with 10 mM HEPES, 100 mM NaCl, 0.05% LDAO, pH 7.5. The IMAC
samples were concentrated via centrifugal filtration (Amicon Ultra-15, Millipore;
100 kDa molecular weight cut-off) to 3–5 ml and loaded onto the column. Proteins
were eluted at 1.3 ml/min and 3 ml fractions were collected. Peak samples were
visualised by SDS-PAGE.
Crystallisation and structure determination. For crystallisation, the final SEC
purification step was carried out in 10 mM HEPES/100 mM NaCl/0.4% C8E4, pH
7.5. Fractions were pooled and concentrated to ~15 mg/ml (molecular weight cut-
off (MWCO) 100 kDa), aliquoted and flash-frozen in liquid nitrogen. Sitting drop
crystallisation trials were set up using a Mosquito crystallisation robot (TTP
Labtech) with commercial screens (Molecular Dimensions MemGold 1 and 2 and
Morpheus). Optimisation was performed with larger-volume hanging drops set up
manually. Well-diffracting crystals for apo-Bt1762-63 were obtained from Mem-
Gold 2, condition 18 (0.15 M sodium formate, 0.1 M HEPES pH 7–7.5, 16–20% w/v
PEG 3350), and were cryoprotected by the addition of ~20–25% PEG400 for
~5–10 s before being flash-frozen in liquid nitrogen. Diffraction data were collected
at 100 K at the Diamond Light Source (Didcot, UK) on beamline i03. Data were
processed via Xia249 or Dials50. The structure was solved by molecular replacement
with Phaser51, using data to 2.62 Å resolution. The previous structure of Bt1762-63
(PDB 5T3R)15 was used as a search model. The model was built iteratively by
manually building in COOT52, and was refined with Phenix53 using TLS refine-
ment with 1 group per chain. Structure validation was carried out with Mol-
Probity54. The model has 94.0% of residues in the favoured regions of the
Ramachandran plot, and 0.7% outliers. The structures of Bt1762-63 with bound
FOS were obtained by incubation of purified complex with 2.5 mM of the
appropriate FOS at room temperature, followed by setting up crystal plates as
above. Models of the bound FOS were generated with JLigand within CCP455 and
fit manually into the density in COOT. Refinement was carried out within Phenix53
as above. The FOS-bound structures have 90.5/1.0% (PDB ID 6Z9A) and 94.1/0.6%
(PDB ID 6ZAZ) of residues in the favourable/disallowed regions of the
Ramachandran plot.
Cryo-EM sample preparation and data collection. A sample of purified Bt1762-
1763 solubilised in an LDAO-containing buffer (10 mM HEPES, pH 7.5, 100 mM
NaCl, 0.05% LDAO) was prepared at 0.02 mg/ml. Lacy carbon 300-mesh copper
grids coated with a <3 nm continuous carbon film (Agar Scientific) were glow-
discharged in air (10 mA, 30 s). A sample volume of 3.5 μl was applied to each grid.
Blotting and plunge freezing were carried out using a Vitrobot Mark IV (FEI) with
the chamber conditions set at a temperature of 4 °C and 100% relative humidity. A
blot force of 6 and a blot time of 6 s were used prior to vitrification in liquid
nitrogen-cooled liquid ethane. Micrograph movies were collected on a Titan Krios
microscope (Thermo Fisher) operating at 300 kV with a GIF energy filter (Gatan)
and K2 Summit direct electron detector (Gatan) operating in counting mode. Data
acquisition parameters can be found in Supplementary Table 2.
Image processing. Following cryo-EM data collection, the RELION (v3.0) pipeline
was used for image processing56,57. Drift correction was performed using
MotionCor258 and contrast transfer functions were estimated using gCTF59.
Approximately 3000 particles were manually picked, extracted and classified in 2D
to provide templates for automated particle picking within RELION. Particles were
extracted in 264 × 264 pixel boxes binned to 132 × 132 for initial rounds of 2D and
3D classification. The 3D starting model was generated de novo from the EM data
by stochastic gradient descent in RELION. The particle stack was cleaned using
both 2D and 3D classification and the remaining particles were unbinned. Further
rounds of 3D classification revealed significant conformational heterogeneity in the
data. Three predominant conformational states of the levan transport system were
identified: OO, OC and CC. Additional classes, while less populated, revealed states
with the Bt1762 “lid” open to differing extents (Supplementary Fig. 4). Invariably,
the closed position of Bt1762 was associated with an absence of density for the plug
domain of Bt1763. Global 3D classification was unable to distinguish “true” closed
conformations from those where Bt1762 occupied a marginally open state. As a
result, a masked 3D classification approach was employed to achieve homogeneous
particle stacks. The masked classification was performed without image alignment
and, since the region of interest is relatively small, the regularisation parameter, T,
was set to 20. Intermediate results and further details are provided in Supple-
mentary Fig. 13. Clean particle stacks for the three principle conformational states
were subject to multiple rounds of CTF refinement and Bayesian polishing57.
C2 symmetry was applied to both the OO and CC reconstructions. Post processing
was performed using soft masks and yielded reconstructions for the OO, OC and
CC states of 3.9, 4.7 and 4.2 Å, respectively, as estimated by gold standard Fourier
Shell correlations using the 0.143 criterion.
Model building into cryo-EM maps. Comparing the maps to the crystal structure
of Bt1762-1763 revealed that their handedness was incorrect. Maps were, therefore,
Z-flipped in UCSF Chimera60. The reconstruction of the OO state was of sufficient
resolution for model building and refinement. Bt1762 and Bt1763 subunits from
the crystal structure were independently rigid body fit to the local resolution fil-
tered map and later subjected to several iterations of manual refinement in
COOT52 and “real space refinement” in Phenix53. The asymmetric unit was
symmetrised in Chimera after each iteration. Molprobity54 was used for model
validation. The reconstructions of the OC and CC states were of insufficient
resolution to permit model building and refinement owing to low particle numbers
and a poor distribution of viewing angles, respectively. Instead, the crystal structure
of Bt1762-1763 was rigid body fit to the CC state. The ligand was removed from the
model and an inspection in COOT showed that no density extended past Lys213 in
the direction of the N terminus. All residues N terminal of Lys213 were therefore
removed from the model before rigid body fitting. The open state from the OO EM
structure and the closed state from the crystal structure (modified as described
above) were rigid body fit to their corresponding densities in the OC state. Rigid
body fitting was performed in Phenix.
Expression and purification of recombinant enzymes. Recombinant pET vectors
(containing either Bt1760 levanase19 or Bacillus levansucrase genes) were trans-
formed into E. coli Tuner cells (Novagen) with appropriate antibiotic selection.
One-litre cultures in 2 l flasks were grown to mid-exponential phase at 37 °C in an
orbital shaker at 150 r.p.m, then cooled to 16 °C and induced with 1 mM isopropyl
β-D-thiogalactopyranoside. These cultures were then incubated for a further 16 h at
16 °C and 150 r.p.m. Cells were harvested by centrifugation, lysed by sonication
and the recombinant His-tagged protein purified from cell-free extracts using
IMAC (Talon resin, Clontech) as previously described19.
Expression and purification of the NTE. A pBAD24 vector carrying the Bt1763
NTE domain with an N-terminal His6 tag (Supplementary Fig. 6), arabinose
promoter and ampicillin resistance was transformed into E. coli BL21 (DE3) Lemo
cells for expression. Cells were grown in M9 MM containing 15NH4Cl and 13C-
glucose as the source of nitrogen and carbon for protein labelling. Cells were grown
at 37 °C for protein expression. At the optical density of 0.7, cells were induced
with 0.1% L-arabinose for 3 h. Cells were then harvested by centrifugation at
4400 × g for 15 min, and resuspended in buffer A (20 mM HEPES, 150 mM NaCl,
pH 7.5) containing lysozyme, DNAse and protease inhibitor. Homogenised cells
were lysed by three rounds passing through a high-pressure microfluidizer. The
lysate was centrifuged at 20,000 × g for 30 min at 4 °C. The supernatant was loaded
on a Ni-NTA His-trap column (GE Healthcare), washed with 10 column volume of
buffer A containing 30 mM imidazole. 15N, 13C-labelled NTE was then eluted with
three column volumes buffer A containing 200 mM imidazole. Eluted proteins
were loaded on Superdex S75 gel filtration column pre-equilibrated with NMR
buffer containing 20 mM sodium phosphate, 150 mM NaCl pH 7.5. Fractions
corresponding to pure NTE were concentrated through a 5 kDa cut-off filter for
NMR spectra acquisitions. The NMR sample contained 250 µl 1 mM U-15N, 13C-
NTE in NMR buffer containing 5% 2H2O.
NMR experiments. All NMR spectra were recorded at 20 °C on a Bruker Avance-
700 spectrometer equipped with a cryogenic triple-resonance probe and using
Topspin 3.6. The proton chemical shifts were referenced to water, and 15N and 13C
were indirectly referenced. 2D [15N,1H]-HSQC, 2D [13C,1H]-HSQC, 3D
HNCACB, 3D CBCA(CO)NH, 3D 15N-resolved-[1H,1H]-NOESY and 3D 13C-
resolved-[1H,1H]-NOESY were acquired for backbone resonance assignment and
structure determination of NTE. The NMR experiments and respective acquisition
parameters are listed in Supplementary Tables 3 and 4.
Calculation of the 3D solution structure of NTE. The side-chain chemical shifts
were assigned automatically using FLYA algorithm with fixed backbone chemical
shifts61. 1H-15N and 1H-13C NOE cross-peaks were automatically assigned fol-
lowed by manual corrections, resulting in a total of 964 unambiguously assigned
peaks. Backbone torsion angle constraints were derived from chemical shift values
using the program TALOS62. Using these values, the solution structure calculation
was performed using the program CYANA63.
FOS production and purification. Two grams of E. herbicola levan (Sigma-
Aldrich) were dissolved in 100ml phosphate-buffered saline (PBS) (Oxoid) by
autoclaving. The solution was cooled to room temperature before the addition of
100 nM Bt1760 GH32 endo-acting levanase and incubated at 37 °C for 30 min to
partially digest the levan to a mixture of different size β2,6 FOS. The enzyme was
then heat inactivated by boiling for 20min. The resultant sample was freeze dried
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using a Christ Alpha 1-2 Freeze Drier at −45 °C. The freeze-dried FOS mixture was
resuspended in 5 ml 50mM acetic acid and loaded onto a column (two 2.5 × 80 cm2
Glass Econo-Columns, connected in series with a flow adaptor; Bio-Rad) packed
with P2 Bio-gel size-exclusion resin (Bio-Rad) and pre-equilibrated with 50 mM
acetic acid. The column was run at 0.25 ml/min using a peristaltic pump (LKB
Bromma 2132 microperpex) and 2ml fractions were collected continuously for 48 h
using a Bio-Rad model 2110 fraction collector. Fractions were initially analysed by
TLC and any that contained sugar were freeze dried to remove acetic acid.
Thin-layer chromatography. TLC plates (Silica gel 60, Sigma-Aldrich) were cut to
the required size, and samples were spotted 1 cm from the bottom of the plate.
These were dried using a hair dryer and placed into a tank containing 1 cm of
running buffer (1-butanol, acetic acid and water at 2:1:1). Once the running buffer
migrated to 1 cm from the top of the plate, the plate was then dried and run again.
To visualise sugars, the plates were completely dried and submerged in developer
solution (sulphuric acid, ethanol and water at 3:70:20 with 1% orcinol) for 5–10 s.
Finally, the plate was dried using a hair dryer and incubated at 65 °C in a drying
oven until developed (usually ~1 h).
Isothermal titration calorimetry. SEC-purified Bt1762-63-SusCD complex was
dialysed overnight at 4 °C with 50 kDa MWCO dialysis tubing into 100 mM
HEPES, pH 7.5, containing 0.05% LDAO. The dialysis buffer was used to resus-
pend SEC-purified FOS fractions produced by partial digestion of Erwinia levan.
ITC was performed using a MicroCal PEAQ-ITC machine with v1.21 control
software for data collection (Malvern Panalytical). Briefly, pure SusCD complex
(25–50 µM; concentration determined by A280) in a 200 µl reaction well was
injected 20 times with 2 µl aliquots of FOS (0.25–4.5 mg/ml) at 25 °C. Integrated
heats were fit to a one set of sites model using the Microcal PEAQ-ITC analysis
software v1.30 (Malvern Panalytical) to obtain Kd, DH and N (number of binding
sites on the protein). For most titrations, the molar concentration of ligand used for
the fits was based on the DP of the major FOS species present as determined by the
TLC and MS analysis. For fractions 118–115, the concentration of ligand was
varied such that N= 1.
Native MS. Proteins were buffer exchanged into 0.5% C8E4, 0.2 M ammonium
acetate, pH 6.9, using a micro biospin 6 column (Bio-Rad). The FOS sample was
diluted to ~500 µM with 0.5 M ammonium acetate, pH 6.9. Mass spectra were
acquired on a Q-Exactive hybrid quadrupole-Orbitrap mass spectrometer (Thermo
Fisher Scientific, Bremen, Germany) optimised for transmission and detection of
high molecular weight protein complexes. About 3 μl of aliquot of the sample was
transferred into gold-coated borosilicate capillary (Harvard Apparatus) prepared
in-house and mounted on the nano-electrospray ionization source. The instrument
settings were 1.2 kV capillary voltage, S-lens RF 200%, argon ultra-high vacuum
pressure 3.1 × 10−10 mbar, capillary temperature 100 °C. Voltages of the ion
transfer optics–injection flatapole, inter-flatapole lens, bent flatapole, and transfer
multipole were set to 5, 3, 2, and 30 V, respectively. The noise level was set at 3.
Protein ions were activated with −120 V with the in-source trapping mode and a
collisional activation voltage of 300 V. Data were visualised and exported for
processing using the Qual browser of Xcalibur 4.2 (Thermo Scientific).
Growth curves. Growth curves were performed in an Epoch microplate spectro-
meter (Biotek Instruments Ltd) with 96-well Costar culture plate (Sigma-Aldrich)
inside an anaerobic cabinet at 37 °C (DonWhitley Scientific, A35 workstation). Media
were inoculated 1:10 with bacterial cultures previously grown overnight in BHI. Final
culture volumes of 200 µl were used, and each condition was performed in triplicate.
Optical density at 600 nm was measured in each well at 30min intervals.
Sources of levan used. In most cases, the levan used was from Erwinia herbicola
(Sigma). For analysis of the growth of the Δ1760 strain, bacterial levans from
Bacillus sp. (Montana Polysaccharides) and Zymomonas mobilis64 (a kind gift from
Prof. Dr. Yekta Göksunger, Ege University, Izmir, Turkey) were also used, as well
as levan from Timothy grass (Megazyme) and in vitro synthesised levan. In vitro
synthesised levan was made using Bacillus subtilis levansucrase incubated with 20%
sucrose in PBS for 24 h at 37 °C. Proteinase K (100 µg/ml) was then added to
remove the protein, before being precipitated out using 0.5% trichloroacetic acid
final. The levan was then extensively dialysed against water and freeze dried.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data supporting the findings of this study are available from the corresponding
authors upon reasonable request. Coordinates and structure factors that support the
findings of this study have been deposited in the Protein Data Bank with accession codes
6ZAZ (Bt1762-63 with shorter FOS), 6Z8I (Bt1762-63 apo) and 6Z9A (Bt1762-63 with
longer FOS). EM structure coordinates have been deposited in the Electron Microscopy
Data Bank with accession codes 6ZLT (OO; EMD-11273), 6ZM1 (OC; EMD-11277) and
6ZLU (CC; EMD-11274). The NMR data have been deposited and publicly released in
the Biological Magnetic Resonance Bank (BMRB) with number 34514. The NTE
structure has been deposited in the Protein Data Bank with accession code 6YTC. Source
data are provided with this paper.
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